{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:11:03Z","timestamp":1779149463367,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Failed extubation within critical care is associated with increased morbidity and mortality. Although the role of high-flow nasal therapy (HFNT) has been established post-extubation, it is not clear whether the delay in establishing HFNT after extubation adversely affects lung physiology, resulting in an increased risk of extubation failure. Early administration of HFNT may prevent lung derecruitment and reduce the rate of extubation failure. Electrical impedance tomography (EIT) is a non-invasive, non-ionising imaging method that allows continuous real-time measurement of lung physiology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a single-centre, unblinded, randomised feasibility trial. Patients who have required intubation and ventilation for the management of acute respiratory failure will be recruited from the critical care unit at Queen Elizabeth University Hospital, Glasgow, Scotland. At the time of their planned extubation, patients will either be randomised to SAFEx extubation (where HFNT is established pre-extubation) or to standard care (where low-flow conventional oxygen therapy is established post-extubation). EIT will be used to compare the lung physiology of these two extubation strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This randomised feasibility trial will provide the relevant information to determine whether a multi-centre feasibility study comparing a SAFEx extubation against standard care is viable. It will also determine the feasibility of using EIT as a measure of changes in lung physiology peri-extubation. As extubation failure remains a significant burden for critical care services, with an associated lack of evidence addressing the impact that the oxygen delivery device has on the outcome of extubation in high-risk patients, this study aims to take the first step in addressing this important research question.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.Gov. Registration number: NCT05904652. Date of registration: 2023-06-15.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40814-026-01817-7","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:05:27Z","timestamp":1775646327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-SAFEx: protocol for a single-centre, randomised, unblinded feasibility trial of Simultaneous Application of Flow at Extubation (SAFEx) in patients requiring intubation and ventilation for the management of acute respiratory failure"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6498-0218","authenticated-orcid":false,"given":"Duncan G.","family":"Thomson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glasiele C.","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm A. B.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"1","key":"1817_CR1","first-page":"59","volume":"9","author":"RC Rothaar","year":"2003","unstructured":"Rothaar RC, Epstein SK. Extubation failure: magnitude of the problem, impact on outcomes, and prevention. Curr Opin Crit Care. 2003;9(1):59\u201366.","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"1817_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/cc11185","volume":"16","author":"JS Krinsley","year":"2012","unstructured":"Krinsley JS, Reddy PK, Iqbal A. What is the optimal rate of failed extubation? Crit Care. 2012;16(1):111.","journal-title":"Crit Care"},{"issue":"5","key":"1817_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jcrc.2010.12.015","volume":"26","author":"F Frutos-Vivar","year":"2011","unstructured":"Frutos-Vivar F, Esteban A, Apezteguia C, Gonz\u00e1lez M, Arabi Y, Restrepo MI, et al. Outcome of reintubated patients after scheduled extubation. J Crit Care. 2011;26(5):502\u20139.","journal-title":"J Crit Care"},{"issue":"10030","key":"1817_CR4","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/S0140-6736(16)30245-8","volume":"387","author":"SD Levy","year":"2016","unstructured":"Levy SD, Alladina JW, Hibbert KA, Harris RS, Bajwa EK, Hess DR. High-flow oxygen therapy and other inhaled therapies in intensive care units. Lancet. 2016;387(10030):1867\u201378.","journal-title":"Lancet"},{"issue":"9","key":"1817_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2044.2008.05536.x","volume":"63","author":"MAB Sim","year":"2008","unstructured":"Sim MAB, Dean P, Kinsella J, Black R, Carter R, Hughes M. Performance of oxygen delivery devices when the breathing pattern of respiratory failure is simulated*. Anaesthesia. 2008;63(9):938\u201340.","journal-title":"Anaesthesia"},{"issue":"1","key":"1817_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-016-1263-z","volume":"20","author":"O Roca","year":"2016","unstructured":"Roca O, Hern\u00e1ndez G, D\u00edaz-Lobato S, Carratal\u00e1 JM, Guti\u00e9rrez RM, Masclans JR. Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Crit Care. 2016;20(1):109.","journal-title":"Crit Care"},{"issue":"10","key":"1817_CR7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.4187\/respcare.02358","volume":"58","author":"RL Parke","year":"2013","unstructured":"Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care. 2013;58(10):1621\u20134.","journal-title":"Respir Care"},{"issue":"23","key":"1817_CR8","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"JP Frat","year":"2015","unstructured":"Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185\u201396.","journal-title":"N Engl J Med"},{"issue":"3","key":"1817_CR9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1164\/rccm.201402-0364OC","volume":"190","author":"SM Maggiore","year":"2014","unstructured":"Maggiore SM, Idone FA, Vaschetto R, Festa R, Cataldo A, Antonicelli F, et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med. 2014;190(3):282\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"1817_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/0885066617705118","volume":"33","author":"H-W Huang","year":"2017","unstructured":"Huang H-W, Sun X-M, Shi Z-H, Chen G-Q, Chen L, Friedrich JO, et al. Effect of high-flow nasal cannula oxygen therapy versus conventional oxygen therapy and noninvasive ventilation on reintubation rate in adult patients after extubation: a systematic review and meta-analysis of randomized controlled trials. J Intensive Care Med. 2017;33(11):609\u201323.","journal-title":"J Intensive Care Med"},{"issue":"15","key":"1817_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jama.2019.14901","volume":"322","author":"AW Thille","year":"2019","unstructured":"Thille AW, Muller G, Gacouin A, Coudroy R, Decav\u00e8le M, Sonneville R, et al. Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA. 2019;322(15):1465\u201375.","journal-title":"JAMA"},{"key":"1817_CR12","doi-asserted-by":"crossref","unstructured":"Bouhemad B, Mongodi S, Via G, Rouquette I. Ultrasound for \u201clung monitoring\u201d of ventilated patients.\u00a0Anesthesiol. 2015;122(2):437-47.","DOI":"10.1097\/ALN.0000000000000558"},{"issue":"7","key":"1817_CR13","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1097\/CCM.0b013e31824e68ae","volume":"40","author":"A Soummer","year":"2012","unstructured":"Soummer A, Perbet S, Brisson H, Arbelot C, Constantin JM, Lu Q, et al. Ultrasound assessment of lung aeration loss during a successful weaning trial predicts postextubation distress*. Crit Care Med. 2012;40(7):2064\u201372.","journal-title":"Crit Care Med"},{"issue":"3","key":"1817_CR14","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/cc9036","volume":"14","author":"IG Bikker","year":"2010","unstructured":"Bikker IG, Leonhardt S, Reis Miranda D, Bakker J, Gommers D. Bedside measurement of changes in lung impedance to monitor alveolar ventilation in dependent and non-dependent parts by electrical impedance tomography during a positive end-expiratory pressure trial in mechanically ventilated intensive care unit patients. Crit Care. 2010;14(3):R100.","journal-title":"Crit Care"},{"key":"1817_CR15","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.2147\/IJGM.S331772","volume":"14","author":"G Wang","year":"2021","unstructured":"Wang G, Zhang L, Li B, Niu B, Jiang J, Li D, et al. The application of electrical impedance tomography during the ventilator weaning process. Int J Gen Med. 2021;14:6875\u201383.","journal-title":"Int J Gen Med"},{"issue":"1","key":"1817_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/thoraxjnl-2016-208357","volume":"72","author":"I Frerichs","year":"2017","unstructured":"Frerichs I, Amato MBP, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group. Thorax. 2017;72(1):83.","journal-title":"Thorax"},{"issue":"1","key":"1817_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13613-019-0565-0","volume":"9","author":"F Longhini","year":"2019","unstructured":"Longhini F, Maugeri J, Andreoni C, Ronco C, Bruni A, Garofalo E, et al. Electrical impedance tomography during spontaneous breathing trials and after extubation in critically ill patients at high risk for extubation failure: a multicenter observational study. Ann Intensive Care. 2019;9(1):88.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"1817_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1817_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391.","journal-title":"Behav Res Methods"},{"issue":"1","key":"1817_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1745-6215-15-264","volume":"15","author":"MD Teare","year":"2014","unstructured":"Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials. 2014;15(1):264.","journal-title":"Trials"},{"key":"1817_CR21","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i5239.","journal-title":"BMJ"},{"issue":"1","key":"1817_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-11-117","volume":"11","author":"M Shanyinde","year":"2011","unstructured":"Shanyinde M, Pickering RM, Weatherall M. Questions asked and answered in pilot and feasibility randomized controlled trials. BMC Med Res Methodol. 2011;11(1):117.","journal-title":"BMC Med Res Methodol"},{"issue":"9","key":"1817_CR23","doi-asserted-by":"publisher","first-page":"e2333642-e","DOI":"10.1001\/jamanetworkopen.2023.33642","volume":"6","author":"X Ying","year":"2023","unstructured":"Ying X, Ehrhardt S. Pilot trial characteristics, postpilot design modifications, and feasibility of full-scale trials. JAMA Netw Open. 2023;6(9):e2333642-e.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1817_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00134-002-1268-8","volume":"28","author":"S Epstein","year":"2002","unstructured":"Epstein S. Decision to extubate. Intensive Care Med. 2002;28(5):535\u201346.","journal-title":"Intensive Care Med"},{"issue":"5","key":"1817_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1183\/09031936.00010206","volume":"29","author":"JM Boles","year":"2007","unstructured":"Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, et al. Weaning from mechanical ventilation. Eur Respir J. 2007;29(5):1033.","journal-title":"Eur Respir J"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-026-01817-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-026-01817-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-026-01817-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:55:50Z","timestamp":1779148550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40814-026-01817-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1186\/s40814-026-01817-7","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was provided by the Scotland A Research Ethics Committee, reference number 23\/SS\/0075, on the 28th of August 2023. Written informed consent will be obtained from all patients recruited for the study. Consent will be sought directly from the patient where possible or from their Nearest Relative\/Guardian or Welfare Attorney (or nearest ward if no suitable Nearest Relative\/Guardian or Welfare Attorney is available) in accordance with the Adults with Incapacity (Scotland) Act 2000 for adults who lack capacity. Trial participants will be informed once they have recovered capacity after extubation that they are free to withdraw from the study at any time, without having to give a reason, and without their current or future care being affected. Written consent will be obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MS has been paid honoraria and travel expenses by Fisher and Paykel Healthcare for presenting at conferences. This has been paid into a research endowment fund. DT has received tuition fees from LINET paid to the University of Glasgow and travel expenses from Fisher and Paykel Healthcare for presenting at a conference. GA receives consulting fees from Timpel Medical. This is an investigator-led study. LINET and Fisher and Paykel Healthcare have had no role in the study design and will have no role in the conduct or interpretation of the results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}